
 
Jun 24, 2010

PR No.:  
144/2010 










PR No.144/2010
Grant of exemption for the proposed acquisition of shares of 
M/s. Panacea Biotec Limited 
 
Dr. K.M. Abraham, Whole Time Member, SEBI, has passed an order dated   June 23, 2010, granting exemption to Mr. Ravinder Jain and others (together referred to as “promoters”) of  M/s. Panacea Biotec Limited (Target Company), from complying with the provisions of Regulation 11(2) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 1997 [Takeover Regulations] with respect to their increase in voting rights by 4.79%, pursuant to the proposed buyback of equity shares by the Target Company. Further the promoters would not be eligible to avail the benefit in terms of second proviso of regulation 11(2) of Takeover Regulations, in future.
 
The application seeking exemption from the provisions of the Takeover Regulations was forwarded by SEBI to the Takeover Panel. The Takeover Panel recommended the grant of exemption to the promoters from making an open offer.
 
The full text of the order is available on the website: www.sebi.gov.in 
 
Mumbai
June 24, 2010

